Anal Canal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Anal Canal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer [Phase 2]
This phase 2 trial update assesses nivolumab with or without ipilimumab in patients with refractory metastatic anal canal cancer, with resul…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study [Phase 2]
Phase 2 DECREASE study is evaluating lower-dose chemoradiation for early-stage anal cancer. The trial is currently active but not recruiting…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer
A clinical trial update examining barriers and delays in diagnosing anal cancer (anal canal squamous cell carcinoma), including HPV-related …
-
EMA approval · 2026-01-30First immunotherapy-based treatment recommended for advanced anal cancer
The European Medicines Agency recommended approval of Zynyz as the first immunotherapy-based treatment option for adults with anal canal squ…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
A clinical trial update describing a multi-omic assessment of squamous cell cancers receiving systemic therapy; currently active but not rec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial [Phase 2]
Feasibility Phase 2 trial evaluating LET-optimized IMPT as part of definitive chemoradiation for newly diagnosed anal canal squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT) [Phase 2]
Phase 2 clinical trial update investigating prebiotics and probiotics during definitive chemoradiotherapy for anal canal squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal [Phase 2]
Phase II trial evaluating concurrent intensity-modulated radiotherapy with Capecitabine, Mitomycin, and Panitumumab in stage II-IIIB anal ca…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. [Phase 2]
A Phase 2 clinical trial completed in Brazil evaluated substituting capecitabine for 5-FU in chemoradiotherapy for squamous cell carcinoma o…